-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OE08UDMiohvuhXvhOwlycTRAcwBz2ImffssfJFeS7PrOhq2kOMCFJ52FpK3RhXyh 4ybJHbcBQQ9k88I/Za05nQ== 0000891836-08-000148.txt : 20080806 0000891836-08-000148.hdr.sgml : 20080806 20080806160548 ACCESSION NUMBER: 0000891836-08-000148 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080806 DATE AS OF CHANGE: 20080806 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDQUIST INC CENTRAL INDEX KEY: 0000884497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 222531298 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42936 FILM NUMBER: 08994971 BUSINESS ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 BUSINESS PHONE: 8568108000 MAIL ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV CENTRAL INDEX KEY: 0000313216 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC BUSINESS PHONE: 31 20 59 77777 MAIL ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V DATE OF NAME CHANGE: 19930727 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS NV DATE OF NAME CHANGE: 19910903 SC 13D/A 1 sc0073.txt SCHEDULE 13, AMENDMENT NO. 8 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 8) MedQuist Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, No Par Value - -------------------------------------------------------------------------------- (Title of Class of Securities) 584949101 - -------------------------------------------------------------------------------- (CUSIP Number) Neil T. Anderson, Esq. Sullivan & Cromwell 125 Broad Street New York, New York 10004-2498 (212) 558-4000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 6, 2008 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If a filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. - -------------------------------------------------------------------------------- CUSIP NO.584949101 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON Koninklijke Philips Electronics N.V. I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 222531298 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. SOURCE OF FUNDS OO - -------------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ] - -------------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands - -------------------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 0 SHARES -------------------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY 0 EACH -------------------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 0 WITH -------------------------------------------------- 10. SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - -------------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% - -------------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- -2- Item 1. Security and Issuer. ------------------- This Amendment No. 8 relates to the common stock, no par value (the "Shares"), of MedQuist Inc., a New Jersey corporation. This Amendment No. 8 amends and supplements Item 4 and Item 5 of the Statement on Schedule 13D dated June 6, 2000 (the "Schedule 13D") filed by Koninklijke Philips Electronics N.V., a corporation incorporated under the laws of The Netherlands ("Philips"), as previously amended and supplemented by Amendment No. 1 to the Schedule 13D, dated July 28, 2000, Amendment No. 2 to the Schedule 13D, dated August 2, 2000, Amendment No. 3 to the Schedule 13D, dated August 24, 2000, Amendment No. 4 to the Schedule 13D, dated July 6, 2007, Amendment No. 5 to the Schedule 13D, dated November 2, 2007, Amendment No. 6 to the Schedule 13D, dated November 8, 2007, and Amendment No. 7 to the Schedule 13D, dated May 22, 2008. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings ascribed to them in the Schedule 13D. Item 4. Purpose of the Transaction. -------------------------- Item 4 is hereby amended and supplemented as follows: Pursuant to the Stock Purchase Agreement, Philips completed the sale (the "Sale") of all of the 26,085,086 Shares it beneficially owned for a stated value of $11.00 per Share (reduced by the $2.75 per Share cash dividend paid to Philips on August 4, 2008), consisting of cash, a promissory note issued by CBay Inc., a subsidiary of CBay ("CBay Inc."), and a seven-year promissory note issued by CBay Inc. convertible into CBay common stock. Pursuant to the Stock Purchase Agreement, the directors of MedQuist appointed by Philips resigned, effective on the election of replacement directors, immediately prior to the completion of the Sale. As a result of the Sale, Philips ceased to be the beneficial owner of any Shares. Item 5. Interest in Securities of Issuer. -------------------------------- Item 5 is hereby replaced in its entirety by the following: (a) As a result of the Sale, Philips ceased to be the beneficial owner of any Shares. (b) As a result of the Sale, Philips ceased to be the beneficial owner of any Shares. (c) On August 6, 2008, Philips announced that the transactions contemplated by the Stock Purchase Agreement had closed and Philips sold to CBay all of the 26,085,086 Shares beneficially owned by Philips. Except for the Sale, Philips has not effected any transaction with respect to the Shares during the past sixty days. (e) As of August 6, 2008, Philips ceased to be beneficial owner of MedQuist shares. (d) Not applicable. (e) On August 6, 2008, as a result of the Sale, Philips ceased to be the beneficial owner of any Shares. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: August 6, 2008 KONINKLIJKE PHILIPS ELECTRONICS N.V. By: /s/ James Nolan ----------------------- Name: James Nolan Title: Attorney-in-Fact -----END PRIVACY-ENHANCED MESSAGE-----